港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药捷安康-B

66.550

-2.300-3.34%

成交量：60.55万

成交额：4,135.48万

市值：265.53亿

市盈率：-92.48

高：71.000

开：69.950

低：66.100

收：68.850

52周最高：679.500

52周最低：20.200

股本：3.99亿

香港流通股本：3.04亿

量比：0.61

换手率：0.20%

股息：- -

股息率：- -

每股收益(LYR):-0.720

净资产收益率：-39.08%

总资产收益率：-21.10%

市净率：40.30

市盈率(LYR):-92.48

市销率: - -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

药捷安康－Ｂ(02617.HK)拟3月31日举行董事会会议审批年度业绩

港股公告掘金 | 腾讯控股发布全年业绩，股东应占盈利2248.42亿元同比增加16% 末期股息每股5.3港元

药捷安康-B(02617)：替恩戈替尼联合氟维司群用于经治失败的HR+/HER2-复发或转移性乳腺癌患者的II期临床完成首例患者给药

一周港股牛熊榜 | 健康160 正式获纳入港股通名单吸引北水参与，一周升逾94%；迅策、中国旭阳集团升近50%强势爆发；联邦制药因盈利预警跌近20%

老虎资讯综合

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":66.55,"timestamp":1774505854804,"preClose":68.85,"halted":0,"volume":605500,"delay":0,"changeRate":-0.03340595497458239,"floatShares":304000000,"shares":399000000,"eps":-0.719596,"marketStatus":"交易中","change":-2.3,"latestTime":"03-26 14:17:40","open":69.95,"high":71,"low":66.1,"amount":41354825,"amplitude":0.071169,"askPrice":66.55,"askSize":1000,"bidPrice":66.45,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.68025,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774512600000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":68.85,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"volumeRatio":0.60914,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":304000000,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.719596,"volumeRatio":0.60914,"shares":399000000,"dividePrice":0,"high":71,"amplitude":0.071169,"preClose":68.85,"low":66.1,"week52Low":20.2,"pbRate":"40.30","week52High":679.5,"institutionHeld":0,"latestPrice":66.55,"committee":-0.333333,"eps":-0.719596,"divideRate":0,"volume":605500,"delay":0,"ttmEps":-0.68025,"open":69.95,"prevYearClose":114.9,"prevWeekClose":68.6,"prevMonthClose":68.9,"prevQuarterClose":114.9,"fiveDayClose":72.2,"twentyDayClose":70.8,"sixtyDayClose":130.2,"earningDate":1774886400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-03-25","current":-99.448732,"percent":0.62234,"low":-380.446233,"twenty":-261.707695,"median":-120.238975,"eighty":-57.612196,"high":-17.403134,"avg":-153.38663,"sd":96.538531,"marketCap":27470987032},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-25","current":-102.28828,"twenty":-261.707695,"median":-120.238975,"eighty":-57.612196,"marketCap":27470987032}],"updateTime":1774497397349},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620416872","title":"药捷安康－Ｂ(02617.HK)拟3月31日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620416872","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620416872?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 18:37","pubTimestamp":1773916624,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨药捷安康－Ｂ(02617.HK)宣布，谨定于2026年3月31日(星期二)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年12月31日止年度的年度业绩公告及其发布、宣派末期股息(如有)以及处理任何其他事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32081894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2620294150","title":"港股公告掘金 | 腾讯控股发布全年业绩，股东应占盈利2248.42亿元 同比增加16% 末期股息每股5.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620294150","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620294150?lang=zh_cn&edition=fundamental","pubTime":"2026-03-19 09:10","pubTimestamp":1773882658,"startTime":"0","endTime":"0","summary":"重大事项：圣贝拉集团(02508)与L Catterton达成战略合作 共同打造跨领域的高端母婴与生活方式生态微创脑科学(02172)：APOLLO Dream雷帕霉素靶向洗脱支架系统荣获FDA突破性医疗器械认定药捷安康-B(02617)：替恩戈替尼联合氟维司群用于经治失败的HR+/HER2-复发或转移性乳腺癌患者的II期临床完成首例患者给药开拓药业-B(09939)：KX-826酊1.0%治疗中","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0414403682.SGD","LU0348783233.USD","SG9999001689.USD","02617","LU1188198961.HKD","LU2498475776.HKD","LU1316542783.SGD","02508","HTCD.SI","SG9999015945.SGD","LU0501845795.SGD","VIG","LU1251922891.USD","LU0572940350.SGD","LU2051468812.USD","LU0348723411.USD","LU0611395673.USD","LU1568876335.HKD","VXUS","SG9999015952.SGD","TCHmain","LU0072913022.USD","00700","BK1531","LU0320764599.SGD","LU1917777945.USD","LU0210533765.USD","LU1152091168.USD","LU0048388663.USD","LU0328353924.USD","LU0791590937.USD","LU0918141705.HKD","LU1655091459.SGD","HK0000306685.HKD","LU0054237671.USD","IE0008368411.USD","LU0577902454.USD","LU1366334578.USD","LU0572944931.SGD","LU1725190679.HKD","LU0633140727.USD","LU1048588211.SGD","IE00B031J352.USD","LU2097828805.USD","LU0048580855.USD","LU1196710864.SGD","LU0516422952.EUR","02172","LU1226287529.USD","LU0648948544.HKD"],"gpt_icon":1},{"id":"2620096232","title":"药捷安康-B(02617)：替恩戈替尼联合氟维司群用于经治失败的HR+/HER2-复发或转移性乳腺癌患者的II期临床完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2620096232","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620096232?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 18:54","pubTimestamp":1773831280,"startTime":"0","endTime":"0","summary":"本试验为在中国开展的一项评价替恩戈替尼联合氟维司群注射液用于经治失败的HR+╱HER2-的复发或转移性乳腺癌患者的安全性、疗效及药代动力学的开放、多中心、II期临床研究。替恩戈替尼早期临床研究结果表明，其单药在经多种治疗的HR+╱HER2 乳腺癌患者中展现出令人鼓舞的临床效果，支持其与内分泌治疗联用的进一步研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HR","BK4203","02617","BK1161","BK4225"],"gpt_icon":0},{"id":"1186668475","title":"一周港股牛熊榜 | 健康160 正式获纳入港股通名单吸引北水参与，一周升逾94%；迅策、中国旭阳集团升近50%强势爆发；联邦制药因盈利预警跌近20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186668475","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186668475?lang=zh_cn&edition=fundamental","pubTime":"2026-03-13 16:45","pubTimestamp":1773391539,"startTime":"0","endTime":"0","summary":"此外，公司被调入港股通后吸引北水参与，市场买盘强劲，连续上涨。2025年7月推出的IAP ROAS优化策略成功切入中重度游戏市场，曝光占比从5.54%迅速提升至18.24%。核心业务中间体及原料药因市场价格下跌，导致分部溢利大幅下降。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01384","02617","02665","01907","02889","02656","01860","03933","03317","02661"],"gpt_icon":1}],"pageSize":4,"totalPage":31,"pageCount":1,"totalSize":121,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02617\",params:#limit:6,delay:false,,,undefined,":[]}}